Verona Pharma plc (VRNA) Financials

VRNA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2025 572.9 million 294.6 million
March 31, 2025 525.9 million 299.3 million
Dec. 31, 2024 474.2 million 269.7 million
Sept. 30, 2024 381.8 million 251.3 million

VRNA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2025 30.6 million 34.8 million
March 31, 2025 -11.6 million 37.5 million
Dec. 31, 2024 -29.4 million 13.7 million
Sept. 30, 2024 -62.7 million 7.7 million

VRNA Net Income

No data available :(

VRNA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2025 - - 1.9 million
March 31, 2025 401.4 million 1.1 million 2.1 million
Dec. 31, 2024 399.8 million 121.6 million 2.4 million
Sept. 30, 2024 336.0 million 121.4 million 2.3 million

VRNA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2025 687.9 million
March 31, 2025 84.9 million
Dec. 31, 2024 81.5 million
Sept. 30, 2024 81.5 million

VRNA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2025 - 13.0 million 72.1 million -
March 31, 2025 535000 14.1 million 69.1 million -
Dec. 31, 2024 535000 7.9 million 45.1 million -
Sept. 30, 2024 45013 10.6 million 35.2 million -

VRNA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2025 103.1 million 4.8 million
March 31, 2025 76.3 million 3.4 million
Dec. 31, 2024 36.7 million 2.0 million
Sept. 30, 2024 5.6 million 543000

VRNA

Price: $106.91

52 week price:
30.77
106.91

Earnings Per Share: -1.04 USD

P/E Ratio: -102.70

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United Kingdom

Volume: 555000

Ebitda: -10.7 million

Market Capitalization: 9.1 billion

Links: